{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:49:50Z","timestamp":1792810190538,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.tjog.2021.11.009","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T18:20:34Z","timestamp":1644949234000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["Polycystic ovarian syndrome-current pharmacotherapy and clinical implications"],"prefix":"10.1016","volume":"61","author":[{"given":"Rumaisa","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail Ahmad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozaifa","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Ara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjum","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiza","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.N.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2021.11.009_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib2","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.tjog.2021.11.009_bib3","series-title":"Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin","author":"Boyle","year":"2012"},{"issue":"16","key":"10.1016\/j.tjog.2021.11.009_bib4","first-page":"2185","article-title":"Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations","volume":"123","author":"Rong","year":"2010","journal-title":"Chinese Med J"},{"issue":"Suppl 2","key":"10.1016\/j.tjog.2021.11.009_bib5","first-page":"S389","article-title":"Prevalence of polycystic ovary syndrome in young women from North India: a Community-based study","volume":"16","author":"Gill","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/2230-8210.131162","article-title":"A\u00a0cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India","volume":"18","author":"Joshi","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpag.2011.03.002","article-title":"Prevalence of polycystic ovarian syndrome in Indian adolescents","volume":"24","author":"Nidhi","year":"2011","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.tjog.2021.11.009_bib8","series-title":"AN overview OF hyperandrogenism IN PCOS and the prospective underlying factors","author":"Abinaya","year":"2019"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.tjog.2021.11.009_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib12","series-title":"The need to reassess the diagnosis of polycystic ovary syndrome (PCOS): a review of diagnostic recommendations from the international evidence-based guideline for the assessment and management of PCOS. Seminars in reproductive medicine","year":"2021"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/GRF.0b013e31802f5197","article-title":"Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician","volume":"50","author":"Lorenz","year":"2007","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2003.01842.x","article-title":"The pathophysiology of polycystic ovary syndrome","volume":"60","author":"Tsilchorozidou","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib16","series-title":"Current medical diagnosis & treatment 2010","author":"McPhee","year":"2010"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cen.12086","article-title":"Sex hormone binding globulin and insulin resistance","volume":"78","author":"Wallace","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib18","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib19","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0277-9536(01)00034-X","article-title":"\u2018The thief of womanhood\u2019: women's experience of polycystic ovarian syndrome","volume":"54","author":"Kitzinger","year":"2002","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17446651.2021.1865152","article-title":"Tailoring treatment for PCOS phenotypes","volume":"16","author":"Papadakis","year":"2021","journal-title":"Expet Rev Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam","year":"2004","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-46644-4","article-title":"Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: an observational study","volume":"9","author":"Manzoor","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2.1.13","article-title":"Polycystic ovarian syndrome: diagnosis and management","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clin Med Res"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.009_bib26","first-page":"1619","article-title":"ACOG releases guidelines on diagnosis and management of polycystic ovary syndrome","volume":"67","author":"Schroeder","year":"2003","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/16.1.36","article-title":"Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome","volume":"16","author":"Falsetti","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tjog.2021.11.009_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy","year":"2011","journal-title":"Int J Wom Health"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"ACOG Practice Bulletin No. 108: polycystic ovary syndrome","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/en.2017-03218","article-title":"Antiandrogen treatment ameliorates reproductive and metabolic phenotypes in the letrozole-induced mouse model of PCOS","volume":"159","author":"Ryan","year":"2018","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(02)04927-0","article-title":"Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism","volume":"79","author":"Lumachi","year":"2003","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.tjog.2021.11.009_bib32","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/humrep\/17.9.2230","article-title":"Should patients with polycystic ovarian syndrome be treated with metformin?","volume":"17","author":"Seli","year":"2002","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.tjog.2021.11.009_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.tjog.2021.11.009_bib34","series-title":"Obesity, metabolic syndrome, and coronary atherosclerosis","author":"Grundy","year":"2002"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dms040","article-title":"Use of metformin for women with polycystic ovary syndrome","volume":"19","author":"Tang","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"11","key":"10.1016\/j.tjog.2021.11.009_bib36","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","author":"ESHRE","year":"2008","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2021.11.009_bib39","series-title":"Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective","author":"Nestler","year":"2008"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1472-6483(10)61099-1","article-title":"Gonadotrophin treatment in patients with polycystic ovary syndrome","volume":"8","author":"Yarali","year":"2004","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"10.1016\/j.tjog.2021.11.009_bib42","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","author":"Tso","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib43","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib44","first-page":"321","article-title":"Myo-inositol vs. D-chiro inositol in PCOS treatment","volume":"67","author":"Formuso","year":"2015","journal-title":"Minerva Ginecol"},{"issue":"23","key":"10.1016\/j.tjog.2021.11.009_bib45","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.3390\/molecules25235566","article-title":"Inositols in PCOS","volume":"25","author":"Kamenov","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.tjog.2021.11.009_bib46","series-title":"Reflections on inositol (s) for PCOS therapy: steps toward success","author":"Nestler","year":"2015"},{"issue":"11","key":"10.1016\/j.tjog.2021.11.009_bib47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/09513590.2011.564685","article-title":"The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome","volume":"27","author":"Minozzi","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/j.1550-8528.1996.tb00271.x","article-title":"Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys","volume":"4","author":"Ortmeyer","year":"1996","journal-title":"Obes Res"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib49","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/endo.135.5.7956944","article-title":"Gonadotropin-releasing hormone (GnRH)-receptor coupling to inositol phosphate and prolactin production in GH3 cells stably transfected with rat GnRH receptor complementary deoxyribonucleic acid","volume":"135","author":"Janovick","year":"1994","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.009_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/09513590.2017.1421632","article-title":"The use of inositol (s) isomers in the management of polycystic ovary syndrome: a comprehensive review","volume":"34","author":"Gateva","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib51","first-page":"5512","article-title":"The 40: 1 myoinositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios","volume":"23","author":"Nordio","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib52","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1002\/jcp.27623","article-title":"Myo-inositol and D-chiro-inositol (40: 1) reverse histological and functional features of polycystic ovary syndrome in a mouse model","volume":"234","author":"Bevilacqua","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib53","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/jcph.362","article-title":"The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome","volume":"54","author":"Dinicola","year":"2014","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib54","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF01204248","article-title":"A\u00a0correlation of the outcome of clinical in\u00a0vitro fertilization with the inositol content and embryotrophic properties of human serum","volume":"9","author":"Chiu","year":"1992","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib55","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/humrep\/17.6.1591","article-title":"Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality","volume":"17","author":"Chiu","year":"2002","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib56","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","article-title":"Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"91","author":"Papaleo","year":"2009","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib57","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1210\/jc.2007-2109","article-title":"Incretin-based therapies in type 2 diabetes mellitus","volume":"93","author":"Chia","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib58","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"Van Can","year":"2014","journal-title":"Int J Obes"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EC-16-0113","article-title":"Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential","volume":"6","author":"Nylander","year":"2017","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12902-017-0155-9","article-title":"Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial","volume":"17","author":"Jensterle","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.tjog.2021.11.009_bib61","series-title":"GLP-1 receptor agonists versus metformin in polycystic ovary syndrome: a systematic review and meta-analysis","author":"Han","year":"2019"},{"key":"10.1016\/j.tjog.2021.11.009_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fendo.2014.00140","article-title":"The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study","volume":"5","author":"Rasmussen","year":"2014","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-015-0005-6","article-title":"The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls","volume":"15","author":"Kahal","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/met.2017.0095","article-title":"Dipeptidyl peptidase-4 inhibitor sitagliptin prevented weight regain in obese women with polycystic ovary syndrome previously treated with liraglutide: a pilot randomized study","volume":"15","author":"Ferjan","year":"2017","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib65","doi-asserted-by":"crossref","first-page":"R848","DOI":"10.1152\/ajpregu.1996.271.4.R848","article-title":"Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats","volume":"271","author":"Tang-Christensen","year":"1996","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib66","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cen.13454","article-title":"Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome","volume":"87","author":"Liu","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.009_bib67","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib68","first-page":"1","article-title":"Effects of metformin and Exenatide on insulin resistance and AMPK\u03b1-SIRT1 molecular pathway in PCOS rats","volume":"12","author":"Tao","year":"2019","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.tjog.2021.11.009_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00189","article-title":"The effect of exenatide on cardiovascular risk markers in women with polycystic ovary syndrome","volume":"10","author":"Dawson","year":"2019","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib70","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/cen.14056","article-title":"Changes in whole metabolites after exenatide treatment in overweight\/obese polycystic ovary syndrome patients","volume":"91","author":"Tang","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib71","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1507\/endocrj.EJ18-0153","article-title":"Circulating zinc-\u03b12-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment","volume":"66","author":"Zheng","year":"2019","journal-title":"Endocr J"},{"issue":"11","key":"10.1016\/j.tjog.2021.11.009_bib72","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1742-1241.2006.01178.x","article-title":"DPP-4 inhibitors and their potential role in the management of type 2 diabetes","volume":"60","author":"Barnett","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib73","doi-asserted-by":"crossref","first-page":"dgz028","DOI":"10.1210\/clinem\/dgz028","article-title":"Sitagliptin decreases visceral fat and blood glucose in women with polycystic ovarian syndrome","volume":"105","author":"Devin","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP-2017-0027","article-title":"DPP4 inhibitor sitagliptin as a potential treatment option in metformin-intolerant obese women with polycystic ovary syndrome: a pilot randomized study","volume":"24","author":"Ferjan","year":"2018","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07435800.2017.1294602","article-title":"Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved \u03b2-cell function and insulin sensitivity in metformin treated PCOS","volume":"42","author":"Jensterle","year":"2017","journal-title":"Endocr Res"},{"key":"10.1016\/j.tjog.2021.11.009_bib76","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cbi.2017.06.009","article-title":"The promising effect of linagliptin and\/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome","volume":"273","author":"Kabel","year":"2017","journal-title":"Chem Biol Interact"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/clpt.2008.251","article-title":"Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib79","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study","volume":"90","author":"Javed","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib80","first-page":"1","article-title":"Licogliflozin effective in PCOS treatment","author":"Tysoe","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib81","series-title":"Licogliflozin versus placebo in women with polycystic ovary syndrome: a randomized, double-blind, phase 2 trial","author":"Tan","year":"2021"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib82","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Group TEA-SPCW","year":"2008","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib83","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/GCO.0b013e328332d188","article-title":"Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance","volume":"21","author":"Palomba","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.tjog.2021.11.009_bib84","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate\u2014end of an era? A mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib85","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib86","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/GCO.0b013e3280c60c9a","article-title":"New advances in ovulation induction","volume":"19","author":"Kafy","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib87","article-title":"Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome","author":"Brown","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tjog.2021.11.009_bib88","doi-asserted-by":"crossref","first-page":"j138","DOI":"10.1136\/bmj.j138","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib89","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1210\/endo-124-5-2297","article-title":"Mevinolin (Lovastatin) inhibits androstenedione production by porcine ovarian theca cells at the level of the 17\u03b1-Hydroxylase: C-17, 20-Lyase complex","volume":"124","author":"Engelhardt","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.tjog.2021.11.009_bib90","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","article-title":"Mevastatin inhibits ovarian theca\u2013interstitial cell proliferation and steroidogenesis","volume":"82","author":"Izquierdo","year":"2004","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib91","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1210\/jc.2010-0770","article-title":"Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability","volume":"95","author":"Sokalska","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.tjog.2021.11.009_bib92","series-title":"Statins in the treatment of polycystic ovary syndrome. Seminars in reproductive medicine","year":"2008"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.009_bib93","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/09513590.2017.1418853","article-title":"Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome","volume":"34","author":"Seyam","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib94","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2013-2674","article-title":"Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study","volume":"98","author":"Puurunen","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib95","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/GRF.0b013e3182353d0f","article-title":"Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome","volume":"54","author":"Casper","year":"2011","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib96","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/GCO.0b013e32833beebf","article-title":"Letrozole for ovulation induction and controlled ovarian hyperstimulation","volume":"22","author":"Pritts","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2004.07.952","article-title":"Single-dose administration of an aromatase inhibitor for ovarian stimulation","volume":"83","author":"Mitwally","year":"2005","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib98","first-page":"244","article-title":"Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovary syndrome","volume":"10","author":"Mitwally","year":"2001","journal-title":"Reprod Technol"},{"key":"10.1016\/j.tjog.2021.11.009_bib99","series-title":"Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?","author":"Polyzos","year":"2008"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2007.08.034","article-title":"Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial","volume":"92","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib101","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib102","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/jcem-44-4-728","article-title":"The inhibitory effect of dopamine agonists on LH release in women","volume":"44","author":"Lachelin","year":"1977","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib103","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jcem-43-3-668","article-title":"Effects of dopamine infusion on pituitary hormone secretion in humans","volume":"43","author":"Leblanc","year":"1976","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1984.tb03445.x","article-title":"The effect of bromocriptine in the polycystic ovary syndrome","volume":"20","author":"Spruce","year":"1984","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-63-1-119","article-title":"A\u00a0double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome","volume":"63","author":"Buvat","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ctcp.2012.01.005","article-title":"Therapeutic effects of calcium & vitamin D supplementation in women with PCOS","volume":"18","author":"dehghani Firouzabadi","year":"2012","journal-title":"Compl Ther Clin Pract"},{"key":"10.1016\/j.tjog.2021.11.009_bib107","first-page":"2020","article-title":"Vitamin D supplementation ameliorates metabolic dysfunction in patients with PCOS: a SystematicReview of RCTs and insight into the Underlying mechanism","author":"Guo","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204748","article-title":"Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): a cross-sectional study","volume":"13","author":"Krul-Poel","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib109","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/09513590.2012.696753","article-title":"Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome","volume":"28","author":"Pal","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.fertnstert.2014.04.046","article-title":"Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review","volume":"102","author":"Irani","year":"2014","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib111","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1210\/jc.2013-4374","article-title":"Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS","volume":"99","author":"Irani","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib112","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jog.13516","article-title":"Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients","volume":"44","author":"Karada\u011f","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2006-948308","article-title":"Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome","volume":"114","author":"Hahn","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib114","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.metabol.2011.03.002","article-title":"Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome","volume":"60","author":"Li","year":"2011","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-09-0432","article-title":"Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome","volume":"161","author":"Wehr","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.dsx.2012.09.006","article-title":"Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome","volume":"6","author":"Patra","year":"2012","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"issue":"8","key":"10.1016\/j.tjog.2021.11.009_bib117","first-page":"2502","article-title":"Vitamin D: a steroid hormone with progesterone-like activity","volume":"22","author":"Monastra","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib118","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.fertnstert.2009.05.019","article-title":"Replete vitamin D stores predict reproductive success following in\u00a0vitro fertilization","volume":"94","author":"Ozkan","year":"2010","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.tjog.2021.11.009_bib119","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/humrep\/des280","article-title":"Characterizing the influence of vitamin D levels on IVF outcomes","volume":"27","author":"Rudick","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00404-013-2959-9","article-title":"Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program","volume":"289","author":"Firouzabadi","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib121","first-page":"1","article-title":"Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: a retrospective cohort study","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Wom Health"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib122","first-page":"319","article-title":"Hormonal and metabolic effects of coenzyme Q10 and\/or vitamin E in patients with polycystic ovary syndrome","volume":"104","author":"Izadi","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib123","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/nu13051677","article-title":"Natural Molecules in the management of polycystic ovary syndrome (PCOS): an analytical review","volume":"13","author":"Iervolino","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-018-0346-x","article-title":"Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Yang","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0190-9622(99)70181-7","article-title":"Methods of hair removal","volume":"40","author":"Olsen","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14764170903449802","article-title":"Unwanted facial hair removal with laser treatment improves quality of life of patients","volume":"12","author":"Maziar","year":"2010","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib127","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ced.12775","article-title":"Laser treatment for female facial hirsutism: are quality-of-life benefits sustainable?","volume":"41","author":"Roche","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2005.01327.x","article-title":"Evidence-based review of hair removal using lasers and light sources","volume":"20","author":"Haedersdal","year":"2006","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.tjog.2021.11.009_bib129","first-page":"1","article-title":"Vaniqa\u2014eflornithine 13.9% cream","volume":"6","author":"Shapiro","year":"2001","journal-title":"Skin Ther Lett"},{"key":"10.1016\/j.tjog.2021.11.009_bib130","series-title":"Ear treatment for excess hair","author":"Muller","year":"2007"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A\u00a0randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib132","first-page":"1237","article-title":"Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial","volume":"32","author":"Smith","year":"2006","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib133","first-page":"65","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib134","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/GRF.0000000000000594","article-title":"Lifestyle modifications in PCOS","volume":"64","author":"Aly","year":"2021","journal-title":"Clin Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib135","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib136","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib137","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod (Oxf)"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib138","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib139","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ajcn\/84.1.77","article-title":"Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome","volume":"84","author":"Moran","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.tjog.2021.11.009_bib141","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/01443610701667338","article-title":"Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management","volume":"27","author":"Farshchi","year":"2007","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-2-35","article-title":"The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study","volume":"2","author":"Mavropoulos","year":"2005","journal-title":"Nutr Metabol"},{"key":"10.1016\/j.tjog.2021.11.009_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.06.013","article-title":"Fasting as possible complementary approach for polycystic ovary syndrome: Hope or hype?","volume":"105","author":"Chiofalo","year":"2017","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.tjog.2021.11.009_bib144","first-page":"56","article-title":"Complementary therapy in polycystic ovary syndrome","volume":"9","author":"Aquino","year":"2014","journal-title":"Translational Medicine@ UniSa"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1745-6215-14-226","article-title":"Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial","volume":"14","author":"Li","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.tjog.2021.11.009_bib146","article-title":"Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction","volume":"2013","author":"Johansson","year":"2013","journal-title":"Evid base Compl Alternative Med"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.009_bib147","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1463-1326.2009.01192.x","article-title":"Acupuncture: is it effective for treatment of insulin resistance?","volume":"12","author":"Liang","year":"2010","journal-title":"Diabetes Obes Metabol"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib148","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/osp4.78","article-title":"Changes in HbA1c and circulating and adipose tissue androgen levels in overweight-obese women with polycystic ovary syndrome in response to electroacupuncture","volume":"2","author":"Stener-Victorin","year":"2016","journal-title":"Obes Sci Pract"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40814-020-00591-4","article-title":"Acupuncture or auricular electro-acupuncture as adjuncts to lifestyle interventions for weight management in PCOS: protocol for a randomised controlled feasibility study","volume":"6","author":"Ee","year":"2020","journal-title":"Pilot Feasibility Stud"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.009_bib150","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1210\/en.2008-0053","article-title":"Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome","volume":"149","author":"Manneras","year":"2008","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib151","first-page":"385","article-title":"Acupuncture ameliorates negative emotion in PCOS patients: a randomized controlled trial","volume":"40","author":"Zhang","year":"2020","journal-title":"Zhongguo Zhen jiu= Chinese Acupuncture & Moxibustion"},{"key":"10.1016\/j.tjog.2021.11.009_bib152","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib153","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib154","first-page":"400","article-title":"Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis","volume":"9","author":"Sherman","year":"2018","journal-title":"Gut Microb"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1152\/physiolgenomics.00114.2017","article-title":"Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis","volume":"50","author":"Jiao","year":"2018","journal-title":"Physiol Genom"},{"issue":"8","key":"10.1016\/j.tjog.2021.11.009_bib156","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib157","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3390\/ijms22042048","article-title":"Microbiome and PCOS: state-of-art and future aspects","volume":"22","author":"Giampaolino","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib158","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/14647273.2017.1283446","article-title":"Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Ahmadi","year":"2017","journal-title":"Hum Fertil"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib159","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s12602-018-9493-9","article-title":"The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials","volume":"11","author":"Heshmati","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.tjog.2021.11.009_bib160","article-title":"Effects of probiotic supplementation on pancreatic \u03b2-cell function and c-reactive protein in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"6","author":"Shoaei","year":"2015","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.tjog.2021.11.009_bib161","first-page":"63","article-title":"Prebiyotikler ve probiyotiklerin diyabet ile iliskisi","volume":"11","author":"Altun","year":"2017","journal-title":"Turk J Life Sci"},{"issue":"5","key":"10.1016\/j.tjog.2021.11.009_bib162","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.clnu.2016.10.003","article-title":"Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: a systematic review","volume":"36","author":"Fernandes","year":"2017","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib163","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00394-018-1648-7","article-title":"The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial","volume":"58","author":"Shamasbi","year":"2019","journal-title":"Eur J Nutr"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib164","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07315724.2019.1657515","article-title":"A\u00a0new approach to polycystic ovary syndrome: the gut microbiota","volume":"39","author":"Yurtda\u015f","year":"2020","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"4","key":"10.1016\/j.tjog.2021.11.009_bib165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153196","article-title":"Association between polycystic ovary syndrome and gut microbiota","volume":"11","author":"Guo","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib166","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41574-019-0255-x","article-title":"IL-22 links gut microbiota to PCOS","volume":"15","author":"Kriebs","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib167","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/JOE-19-0589","article-title":"The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome","volume":"245","author":"Qi","year":"2020","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.tjog.2021.11.009_bib168","doi-asserted-by":"crossref","first-page":"112741","DOI":"10.1016\/j.jep.2020.112741","article-title":"Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: a systematic review and meta-analysis","author":"Heydarpour","year":"2020","journal-title":"J\u00a0Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib169","first-page":"31","article-title":"The effect of metformin and cinnamon on serum anti-mullerian hormone in women having PCOS: a Double-blind, randomized, controlled trial","volume":"10","author":"Wiweko","year":"2017","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.tjog.2021.11.009_bib170","first-page":"100249","article-title":"Efficacy of Darchini in the management of polycystic ovarian syndrome: a randomized clinical study","volume":"15","author":"Khan","year":"2019","journal-title":"J\u00a0Herb Med"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib171","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ptr.5970","article-title":"Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: a randomized double-blind placebo controlled clinical trial","volume":"32","author":"Hajimonfarednejad","year":"2018","journal-title":"Phytother Res"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib172","first-page":"79","article-title":"The effects of flaxseed on weight loss in women with polycystic ovarian syndrome: a randomized controlled trial","volume":"11","author":"Heidari","year":"2019","journal-title":"Iran J Diabetes Obes"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib173","first-page":"1","article-title":"A\u00a0combination of spearmint and flaxseed extract improved endocrine and histomorphology of ovary in experimental PCOS","volume":"13","author":"Mehraban","year":"2020","journal-title":"J\u00a0Ovarian Res"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib174","first-page":"645","article-title":"Hydroalcoholic extract of flaxseed improves polycystic ovary syndrome in a rat model","volume":"21","author":"Jelodar","year":"2018","journal-title":"Iran J Basic Med Sci"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib175","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.37510","article-title":"The effects of combined low-dose oral contraceptives and Vitex agnus on the improvement of clinical and paraclinical parameters of polycystic ovarian syndrome: a triple-blind, randomized, controlled clinical trial","volume":"18","author":"Shahnazi","year":"2016","journal-title":"Iran Red Crescent Med J"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib176","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2305-0500.254647","article-title":"Effect of Vitex agnus-castus plant extract on polycystic ovary syndrome complications in experimental rat model","volume":"8","author":"Hamza","year":"2019","journal-title":"Asian Pac J Reprod"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib177","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/1472-6882-14-511","article-title":"Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo\/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings","volume":"14","author":"Arentz","year":"2014","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.tjog.2021.11.009_bib178","first-page":"1","article-title":"Polycystic ovary syndrome management: a review of the possible amazing role of berberine","author":"Rondanelli","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.tjog.2021.11.009_bib179","article-title":"The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review","volume":"2018","author":"Li","year":"2018","journal-title":"Evid base Compl Alternative Med"},{"issue":"6","key":"10.1016\/j.tjog.2021.11.009_bib180","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1016\/j.clnu.2021.02.004","article-title":"Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS","volume":"40","author":"Mansour","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.tjog.2021.11.009_bib181","first-page":"395","article-title":"The flavanone, naringenin, modifies antioxidant and steroidogenic enzyme activity in a rat model of letrozole-induced polycystic ovary syndrome","volume":"25","author":"Hong","year":"2019","journal-title":"Med Sci Mon Int Med J Exp Clin Res: J Exp Clin Med"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib182","first-page":"1","article-title":"Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review","volume":"13","author":"Tabrizi","year":"2020","journal-title":"J\u00a0Ovarian Res"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib183","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tifs.2014.03.011","article-title":"Flaxseed (Linum usitatissimum L.) bioactive compounds and peptide nomenclature: a review","volume":"38","author":"Shim","year":"2014","journal-title":"Trends Food Sci Technol"},{"issue":"3","key":"10.1016\/j.tjog.2021.11.009_bib184","first-page":"42","article-title":"Effect of hydroalcoholic extract of Vitex agnus-castus fruit on fertility and estrous cycle in letrozole-induced polycystic ovary (PCOS) in rat","volume":"24","author":"Askari","year":"2017","journal-title":"Razi J Med Sci"},{"issue":"10","key":"10.1016\/j.tjog.2021.11.009_bib185","first-page":"865","article-title":"Protective effects of licorice extract on ovarian morphology, oocyte maturation, and embryo development in PCOS-induced mice: an experimental study","volume":"18","author":"Shamsi","year":"2020","journal-title":"Int J Reprod Biomed"},{"issue":"11\u201312","key":"10.1016\/j.tjog.2021.11.009_bib186","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.steroids.2004.09.005","article-title":"Licorice reduces serum testosterone in healthy women","volume":"69","author":"Armanini","year":"2004","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.tjog.2021.11.009_bib187","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2006.10.013","article-title":"Treatment of polycystic ovary syndrome with spironolactone plus licorice","volume":"131","author":"Armanini","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tjog.2021.11.009_bib188","doi-asserted-by":"crossref","first-page":"104544","DOI":"10.1016\/j.yrtph.2019.104544","article-title":"Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K\/AKT and MAPK pathways","volume":"110","author":"Zhang","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.tjog.2021.11.009_bib189","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7918631","article-title":"The effect of berberine on reproduction and metabolism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized control trials","author":"Xie","year":"2019","journal-title":"Evid base Compl Alternative Med"},{"issue":"2","key":"10.1016\/j.tjog.2021.11.009_bib190","first-page":"72","article-title":"Effect of ethanolic seed extract of Caesalpinia bonducella on hormones in mifepristone induced PCOS rats","volume":"10","author":"Meera Murugesan","year":"2020","journal-title":"J\u00a0Appl Pharmaceut Sci"},{"issue":"12","key":"10.1016\/j.tjog.2021.11.009_bib191","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s12298-020-00915-x","article-title":"Rhizomicrobiomics of Caesalpinia bonducella, a wonder plant for PCOS treatment","volume":"26","author":"Ramadurai","year":"2020","journal-title":"Physiol Mol Biol Plants"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455921003132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455921003132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:19:44Z","timestamp":1760897984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455921003132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":191,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1028455921003132"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2021.11.009","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovarian syndrome-current pharmacotherapy and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2021.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}